Trials / Completed
CompletedNCT01550978
Evaluation of the Safety and Efficacy of the AnapnoGuard 100 System
The Safety of Using the AnapnoGuard 100 System in Intubated Critical Care Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hospitech Respiration · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety of using the AnapnoGuard 100 system during the course of mechanical ventilation and intubation of critical care patients in Intensive Care Unit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AnapnoGuard 100 System | AnapnoGuard™ 100 Respiratory Guard System is intended for airway management by oral/nasal intubation while providing continuous endotracheal cuff pressure control using non-invasive measurement and monitoring of carbon dioxide concentration in the subglottic space and evacuation of secretions from above the endotracheal tube's cuff. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2012-03-12
- Last updated
- 2016-02-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01550978. Inclusion in this directory is not an endorsement.